文献速递脑血管病外科

未破裂脑动脉瘤观察与手术治疗的卫生经济学评价

Cost-effectiveness analysis in patients with an unruptured cerebral aneurysm treated with observation or surgery.
PubMed 文献 · J Neurosurg · 2021-05-07

该研究构建决策树与马尔可夫模型,比较未破裂颅内动脉瘤保守观察与 preventive 治疗(血管内治疗联合显微手术夹闭)的成本效果。模型采用三级中心前瞻性收集的 UIA 患者效用值及文献参数,对 55、65、75 岁患者进行蒙特卡洛模拟。结果显示预防性治疗带来更高效用,血管内治疗比例更高、年龄更年轻的模型更具成本效果。

要点

  • 预防性治疗较保守观察带来更高效用,血管内治疗比例高者更具成本效果
  • 基于血管内治疗比例与队列年龄的不同模型,年破裂风险超过 0.8%–1.9% 阈值时治疗具成本效果
  • 血管内治疗比例越高、年龄越轻,成本效果阈值越低

核心结论

  • 未破裂动脉瘤预防性治疗较保守管理带来更高效用,血管内治疗比例更高与年龄更年轻的模型最具成本效果。

研究设计与样本

  • 开发决策树与马尔可夫模型,效用值来自三级中心 UIA 患者队列前瞻性收集,其他参数取自已发表文献。
  • 对 55、65、75 岁患者行蒙特卡洛模拟,比较保守管理与预防性治疗,并模拟不同血管内治疗与显微手术比例。
  • 结局以 QALYs 评估,并行敏感性分析与阈值分析。

主要发现

  • 预防性治疗始终带来更高效用。
  • 血管内治疗比例更高的模型更具成本效果。
  • 年龄较大队列的模型成本效果低于年轻队列。

关键数值与推荐

  • 在支付意愿 < 100,000 USD/QALY 下,各模型年破裂风险超过 0.8%–1.9% 的阈值时治疗具成本效果。
  • 血管内治疗比例更高和年龄更轻可降低该阈值,使低破裂风险动脉瘤的治疗更具成本效果。

临床怎么用

  • 对未破裂动脉瘤决策时可结合年破裂风险与阈值(0.8%–1.9%)评估预防性治疗的成本效果。
  • 治疗方式构成中血管内治疗比例较高、患者较年轻时,预防性治疗的成本效果更优。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The main goal of preventive treatment of unruptured intracranial aneurysms (UIAs) is to avoid the morbidity and mortality associated with aneurysmal subarachnoid hemorrhage. A comparison between the conservative approach and the surgical approach combining endovascular treatment and microsurgical clipping is currently lacking. This study aimed to conduct an updated evaluation of cost-effectiveness comparing the two approaches in patients with UIA. METHODS: A decision tree with a Markov model was developed. Quality-adjusted life-years (QALYs) associated with living with UIA before and after treatment were prospectively collected from a cohort of patients with UIA at a tertiary center. Other inputs were obtained from published literature. Using Monte Carlo simulation for patients aged 55, 65, and 75 years, the authors modeled the conservative management in comparison with preventive treatment. Different proportions of endovascular and microsurgical treatment were modeled to reflect existing practice variations between treatment centers. Outcomes were assessed in terms of QALYs. Sensitivity analyses to assess the model's robustness and completed threshold analyses to examine the influence of input parameters were performed. RESULTS: Preventive treatment of UIAs consistently led to higher utility. Models using a higher proportion of endovascular therapy were more cost-effective. Models with older cohorts were less cost-effective than those with younger cohorts. Treatment was cost-effective (willingness to pay < 100,000 USD/QALY) if the annual rupture risk exceeded a threshold between 0.8% and 1.9% in various models based on the proportion of endovascular treatment and cohort age. A higher proportion of endovascular treatments and younger age lowered this threshold, making the treatment of aneurysms with a lower risk of rupture more cost-effective. CONCLUSIONS: Preventive treatment of aneurysms led to higher utility compared with conservative management. Models with a higher proportion of endovascular treatment and younger patient age were most cost-effective.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Dandurand C, Zhou L, Prakash S, et al. Cost-effectiveness analysis in patients with an unruptured cerebral aneurysm treated with observation or surgery. J Neurosurg. 2021. PMID: 33962376. doi:10.3171/2020.11.JNS202892

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。